Factors and strategies for improving buccal absorption of peptides

被引:137
作者
Veuillez, F
Kalia, YN
Jacques, Y
Deshusses, J
Buri, P
机构
[1] Univ Geneva, Pharm Sect, CH-1211 Geneva 4, Switzerland
[2] Univ Geneva, Sect Biochim, CH-1211 Geneva, Switzerland
[3] Ctr Interuniv Rech & Enseignement, Archamps, France
关键词
buccal mucosa; peptide absorption; enhancement peptide permeation; buccal absorption mechanism; buccal peptide delivery;
D O I
10.1016/S0939-6411(00)00144-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peptides and polypeptides have important pharmacological properties but only a limited number (e.g. insulin, oxytocin, vasopressin) have been exploited as therapeutics because of problems related to their delivery. The buccal mucosa offers an alternative route to conventional, parenteral administration. Peptides are generally not well absorbed through mucosae because of their molecular size, hydrophilicity and the low permeability of the membrane. Peptide transport across buccal mucosa occurs via passive diffusion and is often accompanied by varying degrees of metabolism. This review describes various approaches to improve the buccal absorption of peptides including the use of penetration enhancers to increase membrane permeability and/or the addition of enzyme inhibitors to increase their stability. Other strategies including molecular modification with bioreversible chemical groups or specific formulations such as bioadhesive delivery systems are also discussed. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:93 / 109
页数:17
相关论文
共 175 条
[31]  
Chen W., 1993, Pharmaceutical Research (New York), V10, pS202
[32]  
CHIEN YW, 1996, NOVEL DRUG DELIVERY, P229
[33]  
CHIEN YW, 1996, NOVEL DRUG DELIVERY, P197
[34]  
CHIKHALE EG, 1995, J PHARMACOL EXP THER, V273, P298
[35]   HYDROGEN-BONDING POTENTIAL AS A DETERMINANT OF THE IN-VITRO AND IN-SITU BLOOD-BRAIN-BARRIER PERMEABILITY OF PEPTIDES [J].
CHIKHALE, EG ;
NG, KY ;
BURTON, PS ;
BORCHARDT, RT .
PHARMACEUTICAL RESEARCH, 1994, 11 (03) :412-419
[36]   THE INFLUENCE OF PEPTIDE STRUCTURE ON TRANSPORT ACROSS CACO-2 CELLS [J].
CONRADI, RA ;
HILGERS, AR ;
HO, NFH ;
BURTON, PS .
PHARMACEUTICAL RESEARCH, 1991, 8 (12) :1453-1460
[37]   THE INFLUENCE OF PEPTIDE STRUCTURE ON TRANSPORT ACROSS CACO-2 CELLS .2. PEPTIDE-BOND MODIFICATION WHICH RESULTS IN IMPROVED PERMEABILITY [J].
CONRADI, RA ;
HILGERS, AR ;
HO, NFH ;
BURTON, PS .
PHARMACEUTICAL RESEARCH, 1992, 9 (03) :435-439
[38]   DRUG ABSORPTION THROUGH MUCOSAL MEMBRANES - EFFECT OF MUCOSAL ROUTE AND PENETRANT HYDROPHILICITY [J].
CORBO, DC ;
LIU, JC ;
CHIEN, YW .
PHARMACEUTICAL RESEARCH, 1989, 6 (10) :848-852
[39]   NASAL DELIVERY OF PROGESTATIONAL STEROIDS IN OVARIECTOMIZED RABBITS .2. EFFECT OF PENETRANT HYDROPHILICITY [J].
CORBO, DC ;
HUANG, YC ;
CHIEN, YW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 50 (03) :253-260
[40]  
CORNAZ AL, 1994, EUR J PHARM BIOPHARM, V40, P261